
About REMI
REMI is a publicly listed company based in Mumbai (India) founded in 1960. It operates as a blood bank and laboratory equipment are manufactured by REMI. The company has 182 employees. Its website remilabworld.com draws about 21 thousand monthly visits. Its Indian entity Remi Sales And Engineering Limited reported revenue of βΉ180 Cr. REMI offers products and services including Laboratory Equipment and Healthcare Equipment.
Company details
REMI was established in 1960 and is headquartered in Mumbai, India. Equipment for blood banks and laboratories is produced by the company within the medical and scientific sector. Operations focus on design, fabrication, and distribution of specialized instruments. The domain remilabworld.com supports online presence and client interactions. Activities are centered in India, serving domestic and potential international markets with standard laboratory tools.
- Headquarters Mumbai, India
- Employees 182
- Stage Public
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Phoneβ’β’β’β’ β’β’β’β’
- Website remilabworld.com
- Social LinkedIn X Facebook Instagram YouTube
- Legal Name Remi Sales & Engineering Ltd
- Date of Incorporation 07 Mar, 1980
- Jurisdiction Mumbai, Maharashtra, India
- Annual Revenue₹180 Cr
FY 2025 · +8% YoY
- Net Profit₹9.35 Cr
FY 2025 · 5% margin
- EBITDA₹12.52 Cr
FY 2025 · 7% margin
- Employee Count182
Associated legal entities of REMI
REMI operates through Remi Sales And Engineering Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Remi Sales And Engineering Limited CIN U31100MH1980PLC022314 | Active | 07 Mar 1980 | Mumbai, Maharashtra | ₹180 Cr | 182 | 5 | View details |
Products & Services of REMI
REMI offers a comprehensive portfolio of products and services, including Laboratory Equipment and Healthcare Equipment.
Laboratory instruments such as stirrers and centrifuges are manufactured and supplied to serve scientific and research applications
Healthcare products like blood bank refrigerators and freezers are produced and exported to meet medical and storage requirements
Apps and channels of REMI
its YouTube channel Remi Lab World has 287 subscribers and 30 videos.
Videos from REMI
The most watched videos on REMI's YouTube channel, Remi Lab World (287 subscribers). Click a video to play it here.
More on Remi Lab World.
Board of directors of Remi Sales And Engineering Limited (REMI)
Remi Sales And Engineering Limited is the primary company behind REMI. The board of Remi Sales And Engineering Limited currently have 5 directors; the longest-serving is Vinod Chiranjilal Jalan, appointed in 2021. 6 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Vinod Chiranjilal Jalan DIN 00087424 | Director | 11 Aug 2021 | 5 yrs 2 mo | Remi Sales And Engineering Limited |
| Ritvik Saraf DIN 01638851 | Whole-time director | 01 Dec 2021 | 4 yrs 10 mo | Remi Sales And Engineering Limited |
| Bhagirath Singh DIN 00155407 | Director | 01 Jul 2022 | 4 yrs 3 mo | Remi Sales And Engineering Limited |
| Anita Vinod Bhartiya DIN 01579145 | Director | 30 Sep 2024 | 2 yrs | Remi Sales And Engineering Limited |
| Vishwambhar Chiranjilal Saraf DIN 00161381 | Director | 01 Oct 2024 | 2 yrs | Remi Sales And Engineering Limited |
Financials of REMI
Figures of Remi Sales And Engineering Limited, the primary company behind REMI, for FY 2025. Revenue was ₹180 Cr (+8% year on year). Net profit was ₹9.35 Cr (5% margin). EBITDA was ₹12.52 Cr (7% margin). Revenue has grown at a compounded annual rate of +6% over three years and +5% over five years.
- ₹180 CrRevenue · FY 2025 · +8% YoY
- ₹9.35 CrNet profit · 5% margin
- ₹12.52 CrEBITDA · 7% margin
- ₹57 LakhPaid-up capital
- 182Employees (provident fund records)
- +6%Revenue CAGR, 3 years
- +5%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Remi Sales And Engineering Limited are on its company page.
Detailed financial statements for REMI
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Web traffic of REMI
The website of REMI (remilabworld.com) receives about 21.4K visits a month.
- Monthly visits21.4K
▲ 38.5% vs previous month
Websites whose visitors overlap most with REMI. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| lennox.ie | 100% | – | #2,742,035 | View details | |
shop.nanografi.com | shop.nanografi.com | 96% | – | #1,038,979 | β |
| remigroup.com | 70% | 1.9K | #7,973,445 | View details | |
| bionicsscientific.com | 67% | – | #2,897,486 | View details | |
| tarsons.com | 65% | 41.6K | #738,098 | View details | |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
All 12 similar websites and full traffic analytics for REMI
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 12 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Life Sciences Platforms & Tools
10 companies that operate in the same segment as REMI (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | 1,111 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.34 B | USD 301.49 M | 1,372 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Remi
Complete news archive for REMI
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about REMI
REMI was founded in 1960.
REMI is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
REMI has 182 employees.
The primary company behind REMI, Remi Sales And Engineering Limited, reported revenue of βΉ180 Cr for FY 2025, up 8% year on year.
REMI was established in 1960 and is headquartered in Mumbai, India. Equipment for blood banks and laboratories is produced by the company within the medical and scientific sector. Operations focus on design, fabrication, and distribution of specialized instruments. The domain remilabworld.com supports online presence and client interactions. Activities are centered in India, serving domestic and potential international markets with standard laboratory tools.
REMI offers Laboratory Equipment and Healthcare Equipment.
REMI operates through Remi Sales And Engineering Limited.
The legal entities of REMI currently have 5 directors, including Anita Vinod Bhartiya, Vishwambhar Chiranjilal Saraf, Vinod Chiranjilal Jalan and others.
